Eupraxia Pharmaceuticals INC. (EPRX) — 6-K Filings

All 6-K filings from Eupraxia Pharmaceuticals INC.. Browse 48 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (48)

Eupraxia Pharmaceuticals Files 6-K Report — Apr 22, 2026 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on April 22, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1
6-K Filing — Nov 13, 2025
6-K Filing — Nov 4, 2025
Eupraxia Pharmaceuticals Inc. Files September 2025 6-K Report — Oct 1, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on October 1, 2025, for the month of September 2025. The company, incorporated in Canada with its principal execu
Eupraxia Pharmaceuticals Files 6-K Report — Sep 29, 2025 Risk: medium
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 29, 2025, reporting a Material Change dated September 25, 2025. The company is based in Victoria, Br
Eupraxia Pharmaceuticals Files 6-K Report — Sep 24, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 24, 2025, reporting as a foreign private issuer. The company is incorporated in Canada and its fisca
Eupraxia Pharmaceuticals Files 6-K with Underwriting Agreement — Sep 23, 2025 Risk: medium
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 23, 2025, reporting on activities for the month of September 2025. The filing includes an Underwriti
Eupraxia Pharmaceuticals Files 6-K for September 2025 — Sep 23, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 23, 2025, reporting for the month of September 2025. The company, headquartered in Victoria, British
Eupraxia Pharmaceuticals Files 6-K, Submits Form 40-F — Sep 22, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 22, 2025, indicating it is submitting its annual report under cover of Form 40-F. The company, based
Eupraxia Pharmaceuticals Files 6-K with Material Change Report — Sep 19, 2025 Risk: medium
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 19, 2025, reporting a Material Change Report dated February 20, 2025. The company, based in Victoria
Eupraxia Pharmaceuticals Files 6-K for September 2025 — Sep 2, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 2, 2025, reporting for the month of September 2025. The company, incorporated in Canada and headquar
Eupraxia Pharmaceuticals Files 6-K with Financials — Aug 13, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on August 13, 2025, reporting for the month of August 2025. The filing includes consolidated financial statements
Eupraxia Pharmaceuticals Files 6-K for 2025 Annual Report — Jul 22, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on July 22, 2025, indicating it is submitting its annual report under cover of Form 40-F. The company, located in
Eupraxia Pharmaceuticals Files 6-K — Jul 8, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on July 8, 2025, reporting as a foreign private issuer. The company is incorporated in Canada and its fiscal year
Eupraxia Pharmaceuticals Files 6-K, Submits Form 40-F — Jun 3, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on June 3, 2025, for the month of June 2025. The company, headquartered in Victoria, British Columbia, Canada, is
Eupraxia Pharmaceuticals Files May 2025 Report — Jun 2, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 30, 2025, reporting on activities for the month of May 2025. The filing includes a Management Information
Eupraxia Pharmaceuticals Files 6-K — May 7, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 7, 2025, reporting as a foreign private issuer. The company is incorporated in Canada and its principal ex
Eupraxia Pharmaceuticals Files Q1 2025 Financial Report — May 6, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 6, 2025, reporting its financial results for the three months ended March 31, 2025. The filing includes co
Eupraxia Pharmaceuticals Files 6-K for 2025 Annual Report — May 5, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 5, 2025, indicating it is submitting its annual report under cover of Form 40-F. The company, located in V
Eupraxia Pharmaceuticals Files 6-K — Apr 24, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on April 24, 2025, reporting as a foreign private issuer. The company is incorporated in Canada and its fiscal ye
Eupraxia Pharmaceuticals Files 6-K Report — Mar 21, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on March 21, 2025, reporting on activities for the month of March 2025. The filing includes Exhibit 99.1, a press
Eupraxia Pharmaceuticals Files 6-K Report — Feb 25, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on February 25, 2025, reporting information for the month of February 2025. The filing includes a press release d
Eupraxia Pharmaceuticals Files 6-K Report — Feb 18, 2025 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on February 18, 2025, reporting for the month of February 2025. The filing includes Exhibit 99.1, a press release
Eupraxia Pharmaceuticals Files 6-K Report — Nov 20, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on November 20, 2024, reporting on events for the month of November 2024. The filing includes Exhibit 99.1, which
Eupraxia Pharmaceuticals Files 6-K Report — Nov 14, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on November 14, 2024, reporting for the month of November 2024. The filing includes a press release dated Novembe
Eupraxia Pharmaceuticals Files 6-K Report — Nov 13, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on November 13, 2024, reporting on events for the month of November 2024. The filing includes Exhibit 99.1, a pre
Eupraxia Pharmaceuticals Files 6-K with Financials — Nov 7, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on November 7, 2024, incorporating by reference its consolidated financial statements for the three and nine mont
Eupraxia Pharmaceuticals Files October 2024 6-K Report — Nov 1, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on October 31, 2024, reporting for the month of October 2024. The filing includes Exhibit 99.1, a press release d
Eupraxia Pharmaceuticals Files 6-K Report — Oct 28, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on October 28, 2024, reporting information for the month of October 2024. The filing includes Exhibit 99.1, which
Eupraxia Pharmaceuticals Files 6-K Report — Oct 15, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on October 15, 2024, reporting information for the month of October 2024. The filing includes a press release dat
Eupraxia Pharmaceuticals Files 6-K Report — Oct 10, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on October 10, 2024, reporting information for the month of October 2024. The filing includes Exhibit 99.1, which
Eupraxia Pharmaceuticals Files October 2024 6-K Report — Oct 2, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on October 2, 2024, reporting on its activities for the month of October 2024. The filing includes a press releas
Eupraxia Pharmaceuticals Files 6-K, Includes Press Release — Sep 19, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 19, 2024, reporting for the month of September 2024. The filing indicates that Eupraxia Pharmaceutic
Eupraxia Pharmaceuticals Files 6-K Report — Sep 11, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 11, 2024, reporting information for the month of September 2024. The filing includes Exhibit 99.1, a
Eupraxia Pharmaceuticals Files 6-K, Includes Press Release — Sep 4, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on September 4, 2024, reporting as a foreign private issuer. The filing indicates that the company will file annu
Eupraxia Pharmaceuticals Files 6-K with Financials — Aug 7, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on August 7, 2024, incorporating by reference its consolidated financial statements for the three and six months
Eulexia Pharmaceuticals Files 6-K, Incorporates Press Release — Aug 2, 2024 Risk: low
Eulexia Pharmaceuticals Inc. filed a Form 6-K on August 2, 2024, incorporating a press release dated August 2, 2024, as Exhibit 99.1. This filing is incorporate
Eupraxia Pharmaceuticals Files 6-K Report — Jul 8, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on July 8, 2024, reporting for the month of July 2024. The filing includes Exhibit 99.1, a press release dated Ju
Eupraxia Pharmaceuticals Files July 2024 Report — Jul 3, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on July 3, 2024, reporting on its activities for the month of July. The filing includes a press release dated Jul
Eupraxia Pharmaceuticals Files 6-K with Press Release — Jun 6, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on June 6, 2024, reporting a press release dated June 6, 2024, and a report of voting. This filing incorporates E
Eupraxia Pharmaceuticals Files 6-K Report — Jun 5, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on June 5, 2024, reporting information as of that date. The filing includes Exhibit 99.1, which is a press releas
Eupraxia Pharmaceuticals Files 6-K with Press Release — May 23, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 23, 2024, reporting as a foreign private issuer. The filing includes a press release dated May 23, 2024, a
Eupraxia Pharmaceuticals Files 6-K Report — May 22, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 22, 2024, reporting as a foreign private issuer. The filing includes Exhibit 99.1, a press release dated M
Eupraxia Pharmaceuticals Files 6-K Report — May 21, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 21, 2024, reporting information as a foreign private issuer. The filing includes Exhibit 99.1, a press rel
Eupraxia Pharmaceuticals Files Notice of Shareholder Meeting — May 15, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 15, 2024, to report its Notice of Annual General and Special Meeting of Shareholders. This filing is incor
Eupraxia Pharmaceuticals Files 6-K Report — May 14, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 14, 2024, reporting for the month of May 2024. The filing includes Exhibit 99.1, a press release dated May
Eupraxia Pharmaceuticals Files 6-K with Financial Statements — May 8, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 8, 2024, incorporating by reference its Consolidated Financial Statements. The company is incorporated in
Eupraxia Pharmaceuticals Files 6-K Report — May 2, 2024 Risk: low
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on May 2, 2024, reporting information as of that date. The filing indicates the company is a foreign private issu

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX